Loading…
Lobbying Spend
—
Filings
101
Firms Hired
6
Active Period
1999–2009
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Access to Life-Saving Medicine Act
2008 · fourth_quarter · Firm: FORSCEY, PLLC
Advance proposal to create an FDA process for the approval of generic biological products; S. 316 - Preserve Access to Affordable Generics Act; H.R. 1902 - Protecting Consumer Access to Generic Drugs Act; H.R. 1038 - Access to Life Saving Medicine Act.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 1038
Protecting Consumer Access to Generic Drugs Act of 2007
2008 · fourth_quarter · Firm: FORSCEY, PLLC
Advance proposal to create an FDA process for the approval of generic biological products; S. 316 - Preserve Access to Affordable Generics Act; H.R. 1902 - Protecting Consumer Access to Generic Drugs Act; H.R. 1038 - Access to Life Saving Medicine Act.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 1902
Opposition to changes in legal doctrines of inequitable conduct that would make it harder for generic drug firms to pursue invalidity claims; S. 1145 Patent Reform Act of 2007.
Client expense: — · Firm income: $60,000
Matched citations: S. 1145
Preserve Access to Affordable Generics Act
2008 · fourth_quarter · Firm: FORSCEY, PLLC
Advance proposal to create an FDA process for the approval of generic biological products; S. 316 - Preserve Access to Affordable Generics Act; H.R. 1902 - Protecting Consumer Access to Generic Drugs Act; H.R. 1038 - Access to Life Saving Medicine Act.
Client expense: — · Firm income: $60,000
Matched citations: S. 316
Access to Life-Saving Medicine Act
2008 · fourth_quarter · Firm: STANTON PARK GROUP
Generic Giologics, HR 1956, S1695, HR1038,HR5629, FDA Reform
Client expense: — · Firm income: $30,000
Matched citations: HR1038
Patient Protection and Innovative Biologic Medicines Act of 2007
2008 · fourth_quarter · Firm: STANTON PARK GROUP
Generic Giologics, HR 1956, S1695, HR1038,HR5629, FDA Reform
Client expense: — · Firm income: $30,000
Matched citations: HR 1956
Generic Giologics, HR 1956, S1695, HR1038,HR5629, FDA Reform
Client expense: — · Firm income: $30,000
Matched citations: HR5629
Biologics Price Competition and Innovation Act of 2007
2008 · fourth_quarter · Firm: STANTON PARK GROUP
Generic Giologics, HR 1956, S1695, HR1038,HR5629, FDA Reform
Client expense: — · Firm income: $30,000
Matched citations: S1695
Access to Life-Saving Medicine Act
2008 · fourth_quarter · Firm: FORSCEY, PLLC
Advance proposal to create an FDA process for the approval of generic biological products; S. 316 - Preserve Access to Affordable Generics Act; H.R. 1902 - Protecting Consumer Access to Generic Drugs Act; H.R. 1038 - Access to Life Saving Medicine Act.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 1038
Protecting Consumer Access to Generic Drugs Act of 2007
2008 · fourth_quarter · Firm: FORSCEY, PLLC
Advance proposal to create an FDA process for the approval of generic biological products; S. 316 - Preserve Access to Affordable Generics Act; H.R. 1902 - Protecting Consumer Access to Generic Drugs Act; H.R. 1038 - Access to Life Saving Medicine Act.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 1902
Opposition to changes in legal doctrines of inequitable conduct that would make it harder for generic drug firms to pursue invalidity claims; S. 1145 Patent Reform Act of 2007.
Client expense: — · Firm income: $60,000
Matched citations: S. 1145
Preserve Access to Affordable Generics Act
2008 · fourth_quarter · Firm: FORSCEY, PLLC
Advance proposal to create an FDA process for the approval of generic biological products; S. 316 - Preserve Access to Affordable Generics Act; H.R. 1902 - Protecting Consumer Access to Generic Drugs Act; H.R. 1038 - Access to Life Saving Medicine Act.
Client expense: — · Firm income: $60,000
Matched citations: S. 316
Advance proposal to create an FDA process for the approval of generic biological products; S. 316 - Preserve Access to Affordable Generics Act; H.R. 1902 - Protecting Consumer Access to Generic Drugs Act; H.R. 1038 - Access to Life Saving Medicine Act.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 1038
Protecting Consumer Access to Generic Drugs Act of 2007
2008 · third_quarter · Firm: FORSCEY, PLLC
Advance proposal to create an FDA process for the approval of generic biological products; S. 316 - Preserve Access to Affordable Generics Act; H.R. 1902 - Protecting Consumer Access to Generic Drugs Act; H.R. 1038 - Access to Life Saving Medicine Act.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 1902
Opposition to changes in legal doctrines of inequitable conduct that would make it harder for generic drug firms to pursue invalidity claims; S. 1145 Patent Reform Act of 2007.
Client expense: — · Firm income: $60,000
Matched citations: S. 1145
Preserve Access to Affordable Generics Act
2008 · third_quarter · Firm: FORSCEY, PLLC
Advance proposal to create an FDA process for the approval of generic biological products; S. 316 - Preserve Access to Affordable Generics Act; H.R. 1902 - Protecting Consumer Access to Generic Drugs Act; H.R. 1038 - Access to Life Saving Medicine Act.
Client expense: — · Firm income: $60,000
Matched citations: S. 316
Access to Life-Saving Medicine Act
2008 · third_quarter · Firm: STANTON PARK GROUP
Generic Biologics, HR 1956; S. 1695; Hr 1038; S. 623; HR 5629; FDA Reform
Client expense: — · Firm income: $30,000
Matched citations: Hr 1038
Patient Protection and Innovative Biologic Medicines Act of 2007
2008 · third_quarter · Firm: STANTON PARK GROUP
Generic Biologics, HR 1956; S. 1695; Hr 1038; S. 623; HR 5629; FDA Reform
Client expense: — · Firm income: $30,000
Matched citations: HR 1956
Generic Biologics, HR 1956; S. 1695; Hr 1038; S. 623; HR 5629; FDA Reform
Client expense: — · Firm income: $30,000
Matched citations: HR 5629
Biologics Price Competition and Innovation Act of 2007
2008 · third_quarter · Firm: STANTON PARK GROUP
Generic Biologics, HR 1956; S. 1695; Hr 1038; S. 623; HR 5629; FDA Reform
Client expense: — · Firm income: $30,000
Matched citations: S. 1695
Access to Life-Saving Medicine Act
2008 · third_quarter · Firm: STANTON PARK GROUP
Generic Biologics, HR 1956; S. 1695; Hr 1038; S. 623; HR 5629; FDA Reform
Client expense: — · Firm income: $30,000
Matched citations: S. 623
Access to Life-Saving Medicine Act
2008 · second_quarter · Firm: FORSCEY, PLLC
Advance proposal to create an FDA processs for the approval of generic biological products. S. 316 - Preserve Access to Affordable Generics Act; H.R. 1902 - Protecting Consumer Access to Generic Drugs Act; H.R. 1038 - Access to Life Saving Medicine Act.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 1038
Protecting Consumer Access to Generic Drugs Act of 2007
2008 · second_quarter · Firm: FORSCEY, PLLC
Advance proposal to create an FDA processs for the approval of generic biological products. S. 316 - Preserve Access to Affordable Generics Act; H.R. 1902 - Protecting Consumer Access to Generic Drugs Act; H.R. 1038 - Access to Life Saving Medicine Act.
Client expense: — · Firm income: $60,000
Matched citations: H.R. 1902
Opposition to changes in legal doctrines of inequitable conduct that would make it harder for generic drug firms to pursue invalidity claims; S. 1145 Patent Reform Act of 2007.
Client expense: — · Firm income: $60,000
Matched citations: S. 1145
Preserve Access to Affordable Generics Act
2008 · second_quarter · Firm: FORSCEY, PLLC
Advance proposal to create an FDA processs for the approval of generic biological products. S. 316 - Preserve Access to Affordable Generics Act; H.R. 1902 - Protecting Consumer Access to Generic Drugs Act; H.R. 1038 - Access to Life Saving Medicine Act.
Client expense: — · Firm income: $60,000
Matched citations: S. 316
Source: Senate LDA